148 related articles for article (PubMed ID: 33412960)
1. Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic.
Quinti I; Mezzaroma I; Milito C
Expert Rev Clin Immunol; 2021 Feb; 17(2):163-168. PubMed ID: 33412960
[No Abstract] [Full Text] [Related]
2. COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico.
Castano-Jaramillo LM; Yamazaki-Nakashimada MA; O'Farrill-Romanillos PM; Muzquiz Zermeño D; Scheffler Mendoza SC; Venegas Montoya E; García Campos JA; Sánchez-Sánchez LM; Gámez González LB; Ramírez López JM; Bustamante Ogando JC; Vásquez-Echeverri E; Medina Torres EA; Lopez-Herrera G; Blancas Galicia L; Berrón Ruiz L; Staines-Boone AT; Espinosa-Padilla SE; Segura Mendez NH; Lugo Reyes SO
J Clin Immunol; 2021 Oct; 41(7):1463-1478. PubMed ID: 34114122
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study.
Milota T; Sobotkova M; Smetanova J; Bloomfield M; Vydlakova J; Chovancova Z; Litzman J; Hakl R; Novak J; Malkusova I; Hanzlikova J; Jilek D; Hutyrova B; Novak V; Krcmova I; Sediva A; Kralickova P
Front Immunol; 2022; 13():835770. PubMed ID: 35296097
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity.
Steiner S; Schwarz T; Corman VM; Gebert L; Kleinschmidt MC; Wald A; Gläser S; Kruse JM; Zickler D; Peric A; Meisel C; Meyer T; Staudacher OL; Wittke K; Kedor C; Bauer S; Besher NA; Kalus U; Pruß A; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2022; 13():840126. PubMed ID: 35359967
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.
Meyts I; Bucciol G; Quinti I; Neven B; Fischer A; Seoane E; Lopez-Granados E; Gianelli C; Robles-Marhuenda A; Jeandel PY; Paillard C; Sankaran VG; Demirdag YY; Lougaris V; Aiuti A; Plebani A; Milito C; Dalm VA; Guevara-Hoyer K; Sánchez-Ramón S; Bezrodnik L; Barzaghi F; Gonzalez-Granado LI; Hayman GR; Uzel G; Mendonça LO; Agostini C; Spadaro G; Badolato R; Soresina A; Vermeulen F; Bosteels C; Lambrecht BN; Keller M; Mustillo PJ; Abraham RS; Gupta S; Ozen A; Karakoc-Aydiner E; Baris S; Freeman AF; Yamazaki-Nakashimada M; Scheffler-Mendoza S; Espinosa-Padilla S; Gennery AR; Jolles S; Espinosa Y; Poli MC; Fieschi C; Hauck F; Cunningham-Rundles C; Mahlaoui N; ; Warnatz K; Sullivan KE; Tangye SG
J Allergy Clin Immunol; 2021 Feb; 147(2):520-531. PubMed ID: 32980424
[TBL] [Abstract][Full Text] [Related]
6. Acute and long-term immune responses to SARS-CoV-2 infection in unvaccinated children and young adults with inborn errors of immunity.
García-García A; Fortuny C; Fumadó V; Jordan I; Ruiz-López L; González-Navarro EA; Egri N; Esteve-Solé A; Luo Y; Vlagea A; Cabedo MM; Launes C; Soler A; Codina A; Juan M; Pascal M; Deyà-Martínez A; Alsina L
Front Immunol; 2023; 14():1084630. PubMed ID: 36742319
[TBL] [Abstract][Full Text] [Related]
7. Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.
Goudouris ES; Pinto-Mariz F; Mendonça LO; Aranda CS; Guimarães RR; Kokron C; Barros MT; Anísio F; Alonso MLO; Marcelino F; Valle SOR; Junior SD; Barreto IDP; Ferreira JFS; Roxo-Junior P; do Rego Silva AM; Campinhos FL; Bonfim C; Loth G; Fernandes JF; Garcia JL; Capelo A; Takano OA; Nadaf MIV; Toledo EC; Cunha LAO; Di Gesu RSW; Schidlowski L; Fillipo P; Bichuetti-Silva DC; Soldateli G; Ferraroni NR; de Oliveira Dantas E; Pestana S; Mansour E; Ulaf RG; Prando C; Condino-Neto A; Grumach AS
J Clin Immunol; 2021 Oct; 41(7):1479-1489. PubMed ID: 34164762
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned.
Bucciol G; Tangye SG; Meyts I
Curr Opin Pediatr; 2021 Dec; 33(6):648-656. PubMed ID: 34734915
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era.
Deyà-Martínez A; García-García A; Gonzalez-Navarro EA; Yiyi L; Vlagea A; Jordan I; Fumadó V; Fortuny C; Español M; Launes C; Esteve-Solé A; Juan M; Pascal M; Alsina L
Clin Immunol; 2021 Sep; 230():108821. PubMed ID: 34391937
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity.
Hagin D; Freund T; Navon M; Halperin T; Adir D; Marom R; Levi I; Benor S; Alcalay Y; Freund NT
J Allergy Clin Immunol; 2021 Sep; 148(3):739-749. PubMed ID: 34087242
[TBL] [Abstract][Full Text] [Related]
11. Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations.
Focosi D; Franchini M
Expert Rev Vaccines; 2022 Jul; 21(7):877-884. PubMed ID: 34015243
[TBL] [Abstract][Full Text] [Related]
12. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet).
Giardino G; Milito C; Lougaris V; Punziano A; Carrabba M; Cinetto F; Scarpa R; Dellepiane RM; Ricci S; Rivalta B; Conti F; Marzollo A; Firinu D; Cirillo E; Lagnese G; Cancrini C; Martire B; Danieli MG; Pession A; Vacca A; Azzari C; Fabio G; Soresina A; Agostini C; Spadaro G; Badolato R; Cicalese MP; Aiuti A; Plebani A; Quinti I; Pignata C
J Clin Immunol; 2022 Jul; 42(5):935-946. PubMed ID: 35445287
[TBL] [Abstract][Full Text] [Related]
13. Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency.
Lang-Meli J; Fuchs J; Mathé P; Ho HE; Kern L; Jaki L; Rusignuolo G; Mertins S; Somogyi V; Neumann-Haefelin C; Trinkmann F; Müller M; Thimme R; Umhau M; Quinti I; Wagner D; Panning M; Cunningham-Rundles C; Laubner K; Warnatz K
J Clin Immunol; 2022 Feb; 42(2):253-265. PubMed ID: 34893946
[TBL] [Abstract][Full Text] [Related]
14. Facing up to the COVID-19 pandemic in Argentina.
Rabinovich GA; Geffner J
Nat Immunol; 2021 Mar; 22(3):264-265. PubMed ID: 33627880
[No Abstract] [Full Text] [Related]
15. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
16. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.
Marcus N; Frizinsky S; Hagin D; Ovadia A; Hanna S; Farkash M; Maoz-Segal R; Agmon-Levin N; Broides A; Nahum A; Rosenberg E; Kuperman AA; Dinur-Schejter Y; Berkun Y; Toker O; Goldberg S; Confino-Cohen R; Scheuerman O; Badarneh B; Epstein-Rigbi N; Etzioni A; Dalal I; Somech R
Front Immunol; 2020; 11():614086. PubMed ID: 33519822
[TBL] [Abstract][Full Text] [Related]
17. Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19.
Abolhassani H; Delavari S; Landegren N; Shokri S; Bastard P; Du L; Zuo F; Hajebi R; Abolnezhadian F; Iranparast S; Modaresi M; Vosughimotlagh A; Salami F; Aranda-Guillén M; Cobat A; Marcotte H; Zhang SY; Zhang Q; Rezaei N; Casanova JL; Kämpe O; Hammarström L; Pan-Hammarström Q
J Allergy Clin Immunol; 2022 Nov; 150(5):1059-1073. PubMed ID: 36113674
[TBL] [Abstract][Full Text] [Related]
18. Congenital and acquired defects of immunity: An ever-evolving story.
Castagnoli R; Delmonte OM; Notarangelo LD
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):61-64. PubMed ID: 35080321
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 in unvaccinated patients with inborn errors of immunity-polish experience.
Kołtan S; Ziętkiewicz M; Grześk E; Becht R; Berdej-Szczot E; Cienkusz M; Ewertowska M; Heropolitańska-Pliszka E; Krysiak N; Lewandowicz-Uszyńska A; Mach-Tomalska M; Matyja-Bednarczyk A; Milchert M; Napiórkowska-Baran K; Pieniawska-Śmiech K; Pituch-Noworolska A; Renke J; Roliński J; Rywczak I; Stelmach-Gołdyś A; Strach M; Suchanek H; Sulicka-Grodzicka J; Szczawińska-Popłonyk A; Tokarski S; Więsik-Szewczyk E; Wolska-Kuśnierz B; Zeman K; Pac M
Front Immunol; 2022; 13():953700. PubMed ID: 36211407
[TBL] [Abstract][Full Text] [Related]
20. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
